Autopsy report · NCT02757833

Central Glutathione Levels in Women With Late Life Depression: a Cross Sectional Pilot Feasibility Study

“A larger study collecting the same outcomes is currently being conducted by the study team.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Sponsor type

University, hospital or other

Conditions

Female, Late Life Depression

Interventions

A 3 Tesla MRI scanner (Siemens, Erlangen Germany), will be used to measure levels of GSH in the brain.

Participants

0

Sites

1

Countries

Canada

Trials that died the same way

• Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC
  “Another study enrolling the similar group of patient are ongoing” (66% match in meaning)
• Fracture and Neurological Injury
  “A new version of the study will be submitted” (64% match in meaning)
• Use of Magnetic Imaging to Asses the Efficacy of Cap Assisted Colonoscopy in Reducing Looping and Improving Patient Acceptance for the Colonoscopy Procedure
  “The study was incorporated in another study.” (64% match in meaning)
• Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes
  “study merged with another study” (62% match in meaning)
• Estimate Serum Oxytocin PD Range in the Periphery
  “Study will be replaced by a revised study protocol” (62% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.